
CELLINK, the first bioink company in the world, announced the launch of their new podcast – Biotech Buzz. Here you can get the latest scoop on the world of biotech. CELLINK’s Chief Communications Officer, Ariel Kramer, is the host of Biotech Buzz and will be interviewing industry leaders from around the globe. Biotech Buzz kicked off their podcast with an interview with Jan-Olof Jacke, Sweden’s CEO of pharmaceutical giant AstraZeneca.
You can listen to the first episode now on SoundCloud.
“We are really excited about the launch of Biotech Buzz. This industry is constantly moving at a rapid pace and we want to be a part of keeping the world informed,” said Kramer.
Biotech Buzz will feature researchers, top industry executives and entrepreneurs to name a few, to give their listeners a wide range of interesting content.
Kramer felt it was important to bring in several different types of experts within the industry to show what innovative things are happening on all levels, not just at the top, explaining:
“There are so many amazing things happening on a daily basis. We feel the key to having a successful show is to provide our listeners with different topics every week to keep it fresh and exciting.”
If you’re short on free time, no fear. Biotech Buzz episodes are kept within the 10-20 minute range for a quick on the go-experience.
“We want our listeners to be able to tune in without having to worry about cutting out too much time. Occasionally we will do some longer episodes, but let’s face it, we are living in a fast paced world.” said Kramer.
Erik Gatenholm, CEO of CELLINK, not only envisions CELLINK to be a leader in the world of 3D Bioprinting, but a leader in the world of biotech.
“At CELLINK we believe it’s extremely important to stay up to date and connected within the biotech industry. We love to see what’s happening around the world and what new technologies and discoveries are being made. We want to strengthen the community and we hope that Biotech Buzz will educate and inspire our listeners,” Gatenholm said.
On November 3rd, CELLINK was listed on Nasdaq after only 10 months after starting the company. CELLINK has grown rapidly in this time span from 2 to 15 employees. Their customers include top tier universities and global cosmetic companies.
CELLINK will be broadcasting live at the American Society for Cell Biology (ASCB) meeting in San Francisco and at the Tissue Engineering and Regenerative Medicine International Society (TERMIS) conference in San Diego this December.
If you would like to be a guest on Biotech Buzz or have a suggestion for someone you would like to see on the show, contact the host Ariel Kramer: ak@cellink.com. Discuss in the CELLINK forum at 3DPB.com.
Subscribe to Our Email Newsletter
Stay up-to-date on all the latest news from the 3D printing industry and receive information and offers from third party vendors.
You May Also Like
BAE Systems Taps AML3D to 3D Print Metal Frigate Prototype
BAE Systems Maritime Australia (BAESMA), a division of the UK’s BAE Systems, has given a contract to Australian metal additive manufacturing (AM) original equipment manufacturer (OEM) AML3D, to produce and...
Reshaping Global Supply Chains: The UK’s First Advanced Manufacturing Plan
The day before the Biden administration announced around 30 broad-sweeping economic actions planned by the White House for 2024 and beyond — all surrounding the establishment of a new Council...
$138M to Support Ursa Major’s 3D Printed Rocket Engines
Earlier this year, TechCrunch revealed that Ursa Major Technologies, the Colorado-based startup specializing in using additive manufacturing (AM) for modular rocket engines, had taken in $100 million in its Series...
$1M to Drive Metal 3D Printing Adoption in ASTRO America Project with GE, Pratt & Whitney, and Honeywell
The Applied Science & Technology Research Organization of America (ASTRO America) has partnered with Pratt & Whitney, Honeywell, and GE on a project intended to ease adoption of metal additive...